Researchers at Caltech and their colleagues have identified how at least one brain cancer adapts quickly to therapeutic drugs—and they show that by formulating the right combination of drugs, doctors could potentially overcome this resistance and stop a tumor in its tracks.
On February 26, some of the nation's leading scientists and researchers—including five Nobel laureates and members of all three National Academies—will gather at Caltech to discuss some of the most perplexing questions facing humanity.
Caltech board chair emeritus and longtime Compaq chairman Benjamin M. (Ben) Rosen (BS ’54) and his wife, Donna, have made a bequest commitment to advance scientific exploration at the intersection of biology and engineering.
A new technique developed at Caltech that uses gas-filled microbubbles for focusing light inside tissue could one day provide doctors with a minimally invasive way of destroying tumors with lasers, and lead to improved diagnostic medical imaging.
Thanks to a three-year gift commitment from the Heritage Medical Research Institute (HMRI), Caltech and HMRI have established a new partnership that will provide nine Caltech faculty members with funding support to advance research that relates to medicine and patient care.